Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

Home    

Workshop On Interventions for Metabolic and Endocrine Complications of HIV/AIDS and Drug Abuse


Introduction | Agenda | Abstracts | Recommendations/Participants

AGENDA

Workshop on Interventions for Metabolic and Endocrine Complications of HIV/AIDS and Drug Abuse
November 26-27, 2001

Co-sponsored by
• National Institute on Drug Abuse (NIDA)
• Office of Dietary Supplements (ODS)
• National Center for Complementary and Alternative Medicine (NCCAM)
• National Institutes of Health

Natcher Building (Conference Room D), NIH Campus Bethesda, Maryland

Monday, November 26


Time Event
8:00-8:30 a.m. Registration/Continental Breakfast
8:30-8:40 a.m. Welcome
Jag H. Khalsa, Ph.D. and Paul Coulis, Ph.D.
Center on AIDS and Other Medical Consequences of
Drug Abuse (CAMCODA)
8:40-8:50 a.m. Introduction
Sander Genser, M.D., M.P.H., Head
Medical Consequences Unit, CAMCODA
Henry Francis, M.D., Director, CAMCODA
8:50-9:00 a.m. Opening Remarks
Richard Millstein, Deputy Director, NIDA
9:00-9:10 a.m. The Mission of the Office of Dietary Supplements
Paul Coates, Ph.D., Director, ODS
9:10-9:20 a.m. Missions and Goals of the National Center for Complementary and Alternative Medicine (NCCAM)
Steven Straus, M.D., Director, NCCAM

Metabolic Complications of HIV/AIDS & Drug Abuse

Chair: Sherwood Gorbach, M.D., Professor, Tufts University
Co-Chair: Donald Kotler, M.D., Professor, Columbia University

9:20-9:25 a.m. Introduction
Sherwood Gorbach, M.D., Professor, Tufts University
9:25-9:55 a.m. Difficulties in Understanding Metabolic Complications of HIV/AIDS
Carl Grunfeld, M.D., Ph.D., Professor, University of California, San Francisco
9:55-10:20 a.m. Break
10:20-10:50 a.m. Adipocyte Biology and Lipodystrophy
Donald Kotler, M.D., Professor, Columbia University
10:50-11:00 a.m. Break
11:00-11:30 a.m. Turnover of Adipocytes and Mitochondrial DNA in Humans: Direct Testing of Pathogenic Role in Lipodystrophy and Mitochondrial Toxicity Syndromes
Marc Hellerstein, M.D., Ph.D., Professor, University of California, San Francisco
11:30 a.m.-12:00 p.m. Does Fat Mass Protect Women with HIV from HIV Progression or CD4 Cell Decline?
Clara Jones, M.D., M.P.H., Assistant Professor, Tufts University
12:00-12:30 p.m. Discussion
12:30-1:30 p.m. Lunch On Your Own
1:30-2:00 p.m. Opportunistic Illnesses and Metabolic Complications of HIV/AIDS
Christine Wanke, M.D., Associate Professor, Tufts University
2:00-2:30 p.m. Mechanisms and Strategies for Insulin Resistance in HIV Disease
Steve Grinspoon, M.D., Assistant Professor, Harvard University
2:30-3:00 p.m. Bone Disorders in HIV Infection
Marshall Glesby, M.D., Ph.D., Assistant Professor, Weill Medical College/Cornell University
3:00-3:30 p.m. Discussion
3:15-3:30 p.m. Break

Interventions for Metabolic Complications:
Chair:
Richard Semba, M.D., M.P.H., Associate Professor, The Johns Hopkins University
Co-Chair: Abby Shevitz, M.D., Assistant Professor, Tufts University

3:30-4:00 p.m. Interventions for Visceral Adipocity Associated with HIV/AIDS
Ellen Engelson, Ed.D, Associate Research Scientist, Columbia University
4:00-4:30 p.m. The Effects of Nutrition, Oxandrolone, and Exercise for the Treatment of Wasting from a Randomized Clinical Trial of a Varied Patient Population
Abby Shevitz, M.D., M.P.H., Assistant Professor, Tufts University
4:30-5:00 p.m. Dietary Habits and Metabolic Abnormalities in AIDS Lipodystrophy
Colleen Hadigan, M.D., M.P.H., Assistant Professor, Harvard University
5:00-5:30 p.m. Iron Deficiency Anemia in HIV-Infected and Drug Exposed Women and Children
Richard Semba, M.D., M.P.H., Associate Professor, The Johns Hopkins University
5:30-6:00 p.m. Discussion and Summary of the First Day
Richard Semba, M.D., M.P.H.

Tuesday, November 27

8:00-8:30 a.m. Micronutrients and Health Outcomes Among HIV-infected Women and Children
Wafaie Fawzi, M.D., Associate Professor, Harvard University
8:30-9:00 a.m. Zinc Status in HIV Infection and Drug Abuse
Marianna Baum, Ph.D., Professor, Florida International University
9:00-9:30 a.m. Oxidative Stress and Antioxidant Status in HIV+ and HIV- Injections Drug Users
Alice Tang, Ph.D., Assistant Professor, Tufts University
9:30-9:45 a.m. Discussion
9:45-10:00 a.m. Break

Endocrine Complications of HIV/AIDS and Drug Abuse and Interventions
Chair:
Adrian Dobs, M.D., M.H.S., Professor, The Johns Hopkins University
Co-Chair: Shally Bhasin, M.D., Professor, University of California, Los Angeles

10:00-10:30 a.m. Endocrine Complications of HIV Infection and Substance Abuse in Brazil
Rosita Fontes, M.D., Professor, Catholic University of Rio de Janeiro
10:30-11:00 a.m. Endocrine Complications of HIV/AIDS and Substance Abuse, and Interventions: USA
Adrian Dobs, M.D., M.H.S., Professor, The Johns Hopkins University
11:00-11:30 a.m. Testosterone Effects on Regional Fat Deposition, Insulin Sensitivity, and Atherosclerosis Progression
Shally Bhasin, M.D., Professor, University of California, Los Angeles
11:30-11:45 a.m. Break
11:45 a.m.-12:15 p.m. Metabolic Effects of Growth Hormone Complications in Patients with HIV Infection
Kathleen Mulligan, Ph.D., Assistant Professor, University of California, San Francisco
12:15-12:45 p.m. Alternative Modalities in the Treatment of Endocrine and Metabolic Complications of HIV/AIDS and Drug Abuse
Jerome Ernst, M.D., M.S., Director, Community Research Initiative on AIDS, New York
12:45-1:45 p.m. Discussion and Working Lunch
1:45-2:45 p.m. Breakout Sessions

Group I: Metabolic Complications/Interventions, Open Discussion
Moderators: Carl Grunfeld, M.D., Ph.D./Donald Kotler, M.D. (Room D)

Group II: Endocrine Complications/Interventions, Open Discussion
Moderators: Adrian Dobs, M.D., M.H.S./Shally Bhasin, M.D. (Room F)
2:45-3:45 p.m. Roundtable Open Panel Discussion and Recommendations for Future Research
Moderator: Sherwood Gorbach, M.D.

Issues to cover:
NIDA Portfolio
Future Research

3:45 p.m. Adjourn


What's New Contents




Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal